Elekta: Elekta’s Nomination Committee for the 2014 Annual General Meeting
STOCKHOLM -- October 31, 2013
In accordance with the resolution of the Annual General Meeting on September
3, 2013, Elekta’s (STO:EKTAB) Chairman of the Board has contacted the
company’s five largest shareholders in terms of votes at September 30, 2013 to
form a Nomination Committee. These shareholders have been invited to appoint
one representative each who, together with the Chairman of the Board, will
comprise the Nomination Committee.
Elekta’s Nomination Committee ahead of the 2014 Annual General Meeting
•Laurent Leksell, appointed by the Leksell family, representing the family’s
direct and indirect holdings as well as in his capacity as Chairman of the
Board of Elekta AB.
•Åsa Nisell, appointed by Swedbank Robur funds
•Anders Oscarsson, appointed by AMF Insurance and Funds
•Peter Rudman, appointed by Nordea Investment Funds
•Erik Sjöström, appointed by Skandia Liv
The Nomination Committee will appoint one of its members as Chairman.
The Nomination Committee is tasked ahead of the 2014 Annual General Meeting
with preparing proposals pertaining to the number of Board members, Board
fees, fees for committee work, the composition of the Board, election of the
Chairman of the Board, election of the Chairman of the Annual General Meeting,
auditors’ fees and the election of auditors as well as guidelines for
appointing the Nomination Committee.
The 2014 Annual General Meeting will be held in Stockholm on August 28.
Shareholders wishing to submit proposals to Elekta’s Nomination Committee can
do so by e-mail at email@example.com or by letter to: Elekta AB,
Nomination Committee, Box 7593, SE-103 93 Stockholm, Sweden.
# # #
The above information is such that Elekta AB (publ) shall make public in
accordance with the Securities Market Act and/or the Financial Instruments
Trading Act. The information was published at 14:00 CET on October 31, 2013.
Elekta is a human care company pioneering significant innovations and clinical
solutions for treating cancer and brain disorders. The company develops
sophisticated, state-of-the-art tools and treatment planning systems for
radiation therapy, radiosurgery and brachytherapy, as well as workflow
enhancing software systems across the spectrum of cancer care. Stretching the
boundaries of science and technology, providing intelligent and
resource-efficient solutions that offer confidence to both health care
providers and patients, Elekta aims to improve, prolong and even save patient
Today, Elekta solutions in oncology and neurosurgery are used in over 6,000
hospitals worldwide. Elekta employs around 3,500 employees globally. The
corporate headquarters is located in Stockholm, Sweden, and the company is
listed on the Nordic Exchange under the ticker STO: EKTAB. Website:
This information was brought to you by Cision http://news.cision.com
Tel: +46 702 100 451
Press spacebar to pause and continue. Press esc to stop.